Sabby Management’s Biostage, Inc. Common Stock BSTG Stock Holding History

Sabby Management’s Portfolio BSTG Stock Details BSTG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-55,621	Closed	-$451	–	309
2014 Q3	$451	Buy	55,621 +27,891	+101%	+$228K	0.02%	188
2014 Q2	$290K	Buy	+27,730	New	+$236K	0.01%	213

Other funds holding BSTG

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return

Hussman Strategic Advisors Ellicott City, Maryland $463M AUM 16% 1-Year Est. Return

Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Sabby Management's BSTG Position: Q4 2014 in Review

Sabby Management sold out of Biostage, Inc. Common Stock (BSTG) in Q4 2014, closing a stake of 55,621 shares — an estimated $451 sold.

Sabby Management first reported a position in BSTG in Q2 2014 and held it in 2 quarters. The position peaked at $290K in Q2 2014. 44 funds tracked by Wall St. Rank hold BSTG as of Q4 2014.

Sabby Management reported no remaining Biostage, Inc. Common Stock position as of Q4 2014 after selling out during the quarter.
Sabby Management sold 55,621 Biostage, Inc. Common Stock shares in Q4 2014, an estimated $451.
Sabby Management first reported a position in Biostage, Inc. Common Stock in Q2 2014 and held it in 2 quarters.
Sabby Management's Biostage, Inc. Common Stock position peaked at $290K in Q2 2014.
44 funds tracked by Wall St. Rank held Biostage, Inc. Common Stock as of Q4 2014.

Based on Sabby Management's 13F filing for Q4 2014, filed 17 Feb 2015.